CFDE Data Portal | Search SHLD2P3

	Label	Description
	SHLD2P3 Gene (Entity type)	ENSG00000303991 - shieldin complex subunit 2 pseudogene 3
	GSE128076 doxycycline HEK293 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE233679 nicotinamide 14 v 15 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE208350 H-7 Huh-7 JHH-7 4 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE217776 GSE217829 MLL SGF29 CSNK2A1 knockout U-937 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE186709 GSE186711 MLL inhibition 4 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE182150 KIT LSD1 MYC inhibition 4 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE186709 GSE186711 MLL inhibition 3 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE65634 resveratrol fibroblast 6 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE116133 GSE116136 H-7 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS

SHLD2P3

ENSG00000303991 - shieldin complex subunit 2 pseudogene 3

GSE128076 doxycycline HEK293 1 v 3 human dn

A Gene Set from LINCS

GSE233679 nicotinamide 14 v 15 human up

A Gene Set from LINCS

GSE208350 H-7 Huh-7 JHH-7 4 v 3 human up

A Gene Set from LINCS

GSE217776 GSE217829 MLL SGF29 CSNK2A1 knockout U-937 1 v 0 human dn

A Gene Set from LINCS

GSE186709 GSE186711 MLL inhibition 4 v 6 human dn

A Gene Set from LINCS

GSE182150 KIT LSD1 MYC inhibition 4 v 5 human dn

A Gene Set from LINCS

GSE186709 GSE186711 MLL inhibition 3 v 6 human dn

A Gene Set from LINCS

GSE65634 resveratrol fibroblast 6 v 3 human up

A Gene Set from LINCS

GSE116133 GSE116136 H-7 1 v 0 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.